CYP2J2 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2J2 monoclonal antibodies for research focused on understanding this important enzyme. CYP2J2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2J2 is a member of the cytochrome P450 family and is primarily involved in the metabolism of arachidonic acid, leading to the production of bioactive lipids that play crucial roles in cardiovascular health and inflammation. CYP2J2 expression has been linked to various physiological processes, including vasodilation and the regulation of blood pressure, making it a significant target for research in cardiovascular diseases and drug metabolism. Researchers worldwide utilize CYP2J2 monoclonal antibodies to investigate cellular localization patterns and protein-protein interactions. Advanced detection methods using secondary antibodies conjugated to horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) enable precise visualization of CYP2J2 in experimental settings. Understanding CYP2J2's role in disease progression and therapeutic responses continues to expand through ongoing studies. Santa Cruz Biotechnology monoclonal antibodies for CYP2J2 support researchers in advancing scientific knowledge and developing potential therapeutic strategies for cardiovascular diseases.